The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 2007, 179, 6359 -6367
Copyright © 2007 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Related articles in The JI
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ling, S.
Right arrow Articles by Holoshitz, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ling, S.
Right arrow Articles by Holoshitz, J.

The Rheumatoid Arthritis Shared Epitope Triggers Innate Immune Signaling via Cell Surface Calreticulin1

Song Ling, Xiujun Pi and Joseph Holoshitz2

Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109

The shared epitope (SE), carried by the vast majority of rheumatoid arthritis patients, is a 5-aa sequence motif in the third allelic hypervariable region of the HLA-DRbeta chain. We have recently demonstrated that the SE acts as an allele-specific ligand that triggers NO-mediated pro-oxidative signaling in opposite cells. The identity of the cell surface molecule that interacts with the SE is unknown. Using affinity chromatography purification, cell-binding assays, surface plasmon resonance, and time-resolved fluorescence resonance energy transfer techniques, we have identified cell surface calreticulin (CRT) as the SE-binding molecule. SE-triggered signaling could be blocked by anti-CRT Abs or Abs against CD91 and by CRT-specific antisense or small-interfering RNA oligonucleotides. Embryonic fibroblasts from crt–/– or CD91-deficient mice failed to transduce SE-triggered signals. Exogenously added soluble CRT attached to the cell surface and restored SE-triggered signaling responsiveness in crt–/– cells. These data indicate that cell surface CRT, a known innate immunity receptor, which has been previously proposed as a culprit in autoimmunity, plays a critical role in SE-triggered signal transduction.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 J.H. was supported by grants from the National Institutes of Health (AI47331, AR46468, AR20557, and AR48310) and by Basic Research Grants from the Arthritis Foundation and the American College of Rheumatology. X.P. was supported by Postdoctoral Training Grant AR07080 from the National Institutes of Health.

2 Address correspondence and reprint requests to Dr. Joseph Holoshitz, University of Michigan, 5520D Medical Science Research Building 1, 1150 West Medical Center Drive, Ann Arbor, MI 48109-0680. E-mail address: jholo{at}umich.edu

3 Abbreviations used in this paper: RA, rheumatoid arthritis; SE, shared epitope; SPR, surface plasmon resonance; TR-FRET, time-resolved fluorescence resonance energy transfer; CRT, calreticulin; siRNA, small-interfering RNA; HSP, heat shock protein; MEF, murine embryonic fibroblast; RU, resonance unit.


Related articles in The JI:

IN THIS ISSUE

The JI 2007 179: 5615-5616. [Full Text]  






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2007 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2007 by The American Association of Immunologists, Inc. All rights reserved.